Last updated on September 2016

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)


Brief description of study

The purpose of this study is to investigate the equivalence of JR-131 to Darbepoetin alfa and evaluate the safety of JR-131 in renal anemia patients with chronic kidney disease (CKD).

Clinical Study Identifier: NCT02912494

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kissei Pharmaceutical Co., Ltd

Tokyo and Other Japanese Cities, Japan
  Connect »